The global pharmaceutical industry is worth an estimated $300 billion a year, and the 10 biggest companies of the sector control a full one-third of the total market.
Yet even with all these high-powered corporations, brilliant minds, and mountains of money, the entire business model of this industry is inherently reactive.
A disease exists… A cure is made to address that disease.
A new disease emerges… A new cure is developed.
But this isn’t a weakness — not to Big Pharma, anyway. Because to them, curing a disease means lost revenue.
For the pharmaceutical industry to survive and grow, it needs to keep people buying its products — not turning sick, productive customers into healthy, inactive ones.
Even if their intentions were pure, however, Big Pharma suffers from another inherent flaw: It takes time to make new drugs… years of testing followed by years of going through the process for FDA approval.
In this regard, Mother Nature has a distinct advantage. Creating new diseases is just a matter of mutating the DNA of an existing virus to make something new, frightening, and deadly.
Ebola, for example — as we know it today — can only be transmitted through bodily fluids. A few tweaks of the genetic makeup of this virus, however, and it becomes airborne.
And these mutations can happen any time the virus replicates — something viruses do millions of times a day in every single individual carrier.
You Could Be the Next Patient Zero
Think about that next time you’re in a crowded metro or airliner and somebody next to you starts coughing.
But while Big Pharma chugs along trying to find cures to new diseases, as well as old diseases that have been a scourge on humanity since the dawn of time, a new approach to combating the world’s scariest afflictions is now emerging.
Infectious viruses and parasites like Ebola, MERS, Bubonic plague, and influenza — which killed 100 million people less than a century ago — are capable of sweeping across nations rapidly, infecting and killing millions faster than any company can develop a vaccine.
But they all have one common weakness: relatively short life cycles.
If those already infected can be isolated for long enough, the sickness will die out.
Quarantine, as the process is known, is the only way to stop rapidly spreading infections, and the only way to prevent outbreaks from becoming full-scale epidemics.
Prevention Instead of Cure… The New Paradigm
Well, right now, a small Michigan-based company has come up with a technology that brings this age-old process into the 21st century.
Using the power of modern computers and the magic of modern radio frequency identification (RFID), this small tech company has found a way to track the spread of infection in real time.
Hospitals, clinics, trauma centers, and infectious disease quarantine facilities can now use this incredible new system to determine who is at risk and isolate them before those individuals can come into contact with more people.
It can, in effect, cut off a disease’s ability to spread — regardless of what sort of virus or parasite is posing the danger.
This infection-tracking feature is itself paradigm-shifting to the medical industry, but it’s only one of a host of benefits this company now offers.
Welcome to the Smart Hospital
By tracking every patient, every staff member, and even every mobile piece of equipment in a hospital, the RFID tracking doesn’t just make medical facilities safer; it also increases efficiency, cuts down on patient wait times, cuts down on lost assets, and increases revenues.
It’s a godsend to the nation’s overburdened hospitals because with relatively low overhead, existing facilities can be transformed in a single day to operate at much higher capacity than they were initially designed for.
Right now, some of the nation’s biggest and best-known hospitals are already installing this amazing new system…
But what’s even more interesting is that there are brand-new hospitals being built today that were designed from the ground up with the help of data gathered by this system — a clear indication of how important systems like this will be in the future.
The company that’s pioneering this new technology is small, as I mentioned before. It’s also the only company in the world today that specializes solely in this groundbreaking new technology.
To me, that means one thing: a bright future.
My colleague Alex Koyfman has been researching this company for the last several weeks and just recently published a report detailing his findings.
And let me tell you, they’re nothing short of breathtaking. We could easily be looking at one of the biggest gainers the high-tech sector has seen since the early days of the dot-com revolution.
It’s that impressive and that disruptive to the status quo.
Click here to get Alex’s detailed report right now. You won’t regret it.
To your wealth,
Brian Hicks
Brian is a founding member and President of Angel Publishing and investment director for the income and dividend newsletter The Wealth Advisory. He writes about general investment strategies for Tech Investing Daily, Wealth Daily and Energy & Capital. Known as the “original bull on America,” Brian is also the author of the 2008 book, Profit from the Peak: The End of Oil and the Greatest Investment Event of the Century. In addition to writing about the economy, investments and politics, Brian is also a frequent guest on CNBC, Bloomberg, Fox and countless radio shows. For more on Brian, take a look at his editor’s page.
